Cognition Therapeutics Successfully Passes Pre-defined Futility Analysis of Phase 2 Study of Oral Zervimesine (CT1812) in Geographic Atrophy
Masked Analysis Shows Participants Receiving Oral Zervimesine for at Least 6 Months Experienced Slower Lesion Growth than Participants Receiving ...
Minot Daily News5h
All Conference Grapplers
After competing in regionals for the Northwest Conference (NWC) many wrestlers were given the opportunity to be awarded all ...